DK164163C - Analogifremgangsmaade til fremstilling af 4-oxo-4h-oe1aa-benzopyran-8-yl-alkansyrer eller estere eller dialkylaminoalkylamider deraf eller alkalimetalsalte deraf samt 4-oxo-4h-oe1aa-benzopyran-8-yl-alkannitriler til anvendelse som mellemprodukter - Google Patents

Analogifremgangsmaade til fremstilling af 4-oxo-4h-oe1aa-benzopyran-8-yl-alkansyrer eller estere eller dialkylaminoalkylamider deraf eller alkalimetalsalte deraf samt 4-oxo-4h-oe1aa-benzopyran-8-yl-alkannitriler til anvendelse som mellemprodukter

Info

Publication number
DK164163C
DK164163C DK523082A DK523082A DK164163C DK 164163 C DK164163 C DK 164163C DK 523082 A DK523082 A DK 523082A DK 523082 A DK523082 A DK 523082A DK 164163 C DK164163 C DK 164163C
Authority
DK
Denmark
Prior art keywords
benzopyran
oxo
oe1aa
esters
dialkylaminoalkylamider
Prior art date
Application number
DK523082A
Other languages
Danish (da)
English (en)
Other versions
DK523082A (da
DK164163B (da
Inventor
Philippe Briet
Jean-Jacques Berthelon
Francois Collonges
Original Assignee
Lipha
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lipha filed Critical Lipha
Publication of DK523082A publication Critical patent/DK523082A/da
Publication of DK164163B publication Critical patent/DK164163B/da
Application granted granted Critical
Publication of DK164163C publication Critical patent/DK164163C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/04Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/26Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
    • C07D311/28Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only
    • C07D311/30Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only not hydrogenated in the hetero ring, e.g. flavones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/26Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
    • C07D311/34Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 3 only
    • C07D311/36Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 3 only not hydrogenated in the hetero ring, e.g. isoflavones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrane Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Control Of Motors That Do Not Use Commutators (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK523082A 1981-11-25 1982-11-24 Analogifremgangsmaade til fremstilling af 4-oxo-4h-oe1aa-benzopyran-8-yl-alkansyrer eller estere eller dialkylaminoalkylamider deraf eller alkalimetalsalte deraf samt 4-oxo-4h-oe1aa-benzopyran-8-yl-alkannitriler til anvendelse som mellemprodukter DK164163C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8122020 1981-11-25
FR8122020A FR2516922A1 (fr) 1981-11-25 1981-11-25 Acides (oxo-4-4h-(1)-benzopyran-8-yl) alcanoiques, sels et derives, preparation et medicament les contenant

Publications (3)

Publication Number Publication Date
DK523082A DK523082A (da) 1983-05-26
DK164163B DK164163B (da) 1992-05-18
DK164163C true DK164163C (da) 1992-10-19

Family

ID=9264332

Family Applications (1)

Application Number Title Priority Date Filing Date
DK523082A DK164163C (da) 1981-11-25 1982-11-24 Analogifremgangsmaade til fremstilling af 4-oxo-4h-oe1aa-benzopyran-8-yl-alkansyrer eller estere eller dialkylaminoalkylamider deraf eller alkalimetalsalte deraf samt 4-oxo-4h-oe1aa-benzopyran-8-yl-alkannitriler til anvendelse som mellemprodukter

Country Status (24)

Country Link
US (2) US4602034A (en, 2012)
EP (1) EP0080934B1 (en, 2012)
JP (1) JPS5896082A (en, 2012)
AT (1) ATE31927T1 (en, 2012)
AU (1) AU563190B2 (en, 2012)
CA (1) CA1213595A (en, 2012)
CS (1) CS248035B2 (en, 2012)
DD (1) DD204919A5 (en, 2012)
DE (1) DE3277970D1 (en, 2012)
DK (1) DK164163C (en, 2012)
ES (1) ES8308323A1 (en, 2012)
FR (1) FR2516922A1 (en, 2012)
HU (1) HU192112B (en, 2012)
IE (1) IE54130B1 (en, 2012)
IL (1) IL67291A0 (en, 2012)
IN (1) IN158843B (en, 2012)
MA (1) MA19650A1 (en, 2012)
MX (1) MX173498B (en, 2012)
NO (1) NO159169C (en, 2012)
NZ (1) NZ202596A (en, 2012)
OA (1) OA07257A (en, 2012)
SU (1) SU1250171A3 (en, 2012)
YU (2) YU43726B (en, 2012)
ZA (1) ZA828436B (en, 2012)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2536397A2 (en) * 1981-11-25 1984-05-25 Lipha [4-oxo-4H-1-Benzopyran-8-yl]alkanoic acids, their salts and derivatives, their preparation and medicinal products containing them
DE3311004A1 (de) * 1983-03-25 1984-09-27 Bayer Ag, 5090 Leverkusen Chromon- und thiochromon-8-aldehyde, sowie ein verfahren zu ihrer herstellung
JPS62215581A (ja) * 1986-03-18 1987-09-22 Koichi Shiyudo フラボンカルボン酸誘導体
IL85554A0 (en) * 1987-03-02 1988-08-31 Takeda Chemical Industries Ltd Chromone derivatives
USH1427H (en) * 1988-04-06 1995-04-04 Briet; Phillipe Substituted flavonoid compounds, their salts, their manufacture and their use in combination with interleukin-2
IL89840A (en) * 1988-04-06 1996-10-31 Lipha Substituted flavonoid compounds and salts thereof their preparation and pharmaceutical composition containing them
US5116954A (en) * 1988-04-06 1992-05-26 Lipha, Lyonnaise Industrielle Pharmaceutique Pharmaceutically useful flavonoic compounds containing at least one substituent on the benzopyranone ring moiety
US5126129A (en) * 1988-05-23 1992-06-30 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health & Human Services Cancer therapy using interleukin-2 and flavone compounds
US5238954A (en) * 1989-01-19 1993-08-24 The Upjohn Company Fluorinated flavone acetic acid
DE68913997T2 (de) * 1989-01-19 1994-07-28 Upjohn Co Fluorierte flavon-essigsäure.
SK281016B6 (sk) * 1992-02-05 2000-10-09 Boehringer Ingelheim Kg Amidínové deriváty, spôsob ich výroby, použitie a farmaceutické prostriedky s ich obsahom
US5703130A (en) * 1995-06-07 1997-12-30 Institute Of Materia Medica, An Institute Of The Chinese Academy Of Medical Sciences Chalcone retinoids and methods of use of same
US5716982A (en) * 1995-06-07 1998-02-10 Institute Of Materia Medica, An Institute Of The Chinese Academy Of Medical Sciences Retinoids and methods of use of same
US5968940A (en) * 1995-06-08 1999-10-19 Institute Of Materia Medica Retinoids and methods of use of same
JP4638098B2 (ja) * 1999-06-14 2011-02-23 キャンサー・リサーチ・テクノロジー・リミテッド 癌治療
CA2389924A1 (en) 2000-01-24 2001-07-26 Jozef S. Mruk Use of flavone 8-acetic acid in vascular and cardiovascular interventions and acute coronary syndromes
AU2001282717A1 (en) * 2000-07-28 2002-02-13 Cancer Research Technology Limited Cancer treatment by combination therapy
GB0121285D0 (en) * 2001-09-03 2001-10-24 Cancer Res Ventures Ltd Anti-cancer combinations
GB2386836B (en) * 2002-03-22 2006-07-26 Cancer Res Ventures Ltd Anti-cancer combinations
GB2394658A (en) * 2002-11-01 2004-05-05 Cancer Rec Tech Ltd Oral anti-cancer composition
GB0321999D0 (en) * 2003-09-19 2003-10-22 Cancer Rec Tech Ltd Anti-cancer combinations
JP2009506019A (ja) * 2005-08-26 2009-02-12 アンティソーマ・ピーエルシー 癌治療のための組み合わせ
WO2011023287A1 (en) 2009-08-27 2011-03-03 Merck Patent Gmbh Use of faa and its derivatives in cosmetics and dermatology
DK2496567T3 (en) 2009-11-05 2017-10-30 Rhizen Pharmaceuticals S A PRESENT UNKNOWN BENZOPYRANKINA MODULATORS
CN103304531A (zh) * 2013-06-25 2013-09-18 南方医科大学 一种3-芳基黄酮乙酸
WO2017156520A1 (en) * 2016-03-11 2017-09-14 H. Lee Moffitt Cancer Center And Research Institute, Inc. Icariin and icaritin derivatives

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2921070A (en) * 1957-11-05 1960-01-12 Recordati Lab Farmacologico S Basic esters of 3-methylflavone-8-carboxylic acid
US3350411A (en) * 1963-10-10 1967-10-31 Pharma Seceph S A Soc D Expl C Process for preparing 3-methylflavone-8-carboxylic acid
BE757821A (fr) * 1970-08-01 1971-04-01 Recordati Chem Pharm Procede de preparation de l'acide 3-propionyl-salicylique et dederives de cet acide
GB1479518A (en) * 1973-12-27 1977-07-13 Erba Carlo Spa 5,6-benzo-ypsilon-pyrone derivatives
US4148900A (en) * 1973-12-27 1979-04-10 Carlo Erba S.P.A. 5:6-Benzo-γ-pyrone derivatives and process for their preparation
FR2281112A1 (fr) * 1974-08-05 1976-03-05 Lipha Nouveau medicament choleretique et anti-inflammatoire
GB1469823A (en) * 1974-08-13 1977-04-06 Farma Lepori Flavone derivatives
DE2549745A1 (de) * 1974-11-20 1976-05-26 Lipha Durch einen chromonylrest substituierte propionsaeuren sowie deren derivate und verwendungen

Also Published As

Publication number Publication date
YU43726B (en) 1989-10-31
IE54130B1 (en) 1989-06-21
SU1250171A3 (ru) 1986-08-07
JPH0214352B2 (en, 2012) 1990-04-06
YU264982A (en) 1984-12-31
US4602034A (en) 1986-07-22
YU43675B (en) 1989-10-31
MA19650A1 (fr) 1983-07-01
US4783533A (en) 1988-11-08
NZ202596A (en) 1986-02-21
IE822752L (en) 1983-05-25
NO159169B (no) 1988-08-29
CA1213595A (fr) 1986-11-04
DK523082A (da) 1983-05-26
DK164163B (da) 1992-05-18
OA07257A (fr) 1984-04-30
ES517637A0 (es) 1983-08-16
ZA828436B (en) 1983-09-28
FR2516922B1 (en, 2012) 1984-02-10
AU9073082A (en) 1983-06-02
MX173498B (es) 1994-03-10
EP0080934A1 (fr) 1983-06-08
CS248035B2 (en) 1987-01-15
EP0080934B1 (fr) 1988-01-13
YU163084A (en) 1985-03-20
HU192112B (en) 1987-05-28
IL67291A0 (en) 1983-03-31
DE3277970D1 (en) 1988-02-18
ES8308323A1 (es) 1983-08-16
NO159169C (no) 1988-12-07
DD204919A5 (de) 1983-12-14
JPS5896082A (ja) 1983-06-07
ATE31927T1 (de) 1988-01-15
AU563190B2 (en) 1987-07-02
IN158843B (en, 2012) 1987-01-31
NO823940L (no) 1983-05-26
FR2516922A1 (fr) 1983-05-27

Similar Documents

Publication Publication Date Title
DK164163C (da) Analogifremgangsmaade til fremstilling af 4-oxo-4h-oe1aa-benzopyran-8-yl-alkansyrer eller estere eller dialkylaminoalkylamider deraf eller alkalimetalsalte deraf samt 4-oxo-4h-oe1aa-benzopyran-8-yl-alkannitriler til anvendelse som mellemprodukter
DK443482A (da) Fremgangsmaade til fremstilling af carboxylsyrederivater
DK150064C (da) Analogifremgangsmaade til fremstilling af alfa-(2-hydroxyethyl)-2-oxo-1-pyrrolidineddikesyre samt amider deraf
DE69016567D1 (de) Prostaglandinanaloge enthaltende Lipidemulsion.
DK237483A (da) Fremgangsmaade til fremstilling af propionsyrederivater
EP0395528A3 (fr) Dérivés du 4-phénylméthyl 1H-indole, procédé et intermédiaires de préparation, application à titre de médicaments et compositions les renfermant.
AR018675A1 (es) Derivados de 3-(2-oxo-[1,3¿i¿]bipirrolidinil-3-ilidenometil)-cefem, una composicion farmaceutica y el uso de los mismos para la manufactura de un medicamento.
DK439082A (da) 4-acylamino-1-aza-adamantan-forbindelser samt fremgangsmaade til fremstilling deraf
SE8405275D0 (sv) 1,2-dithiolan derivatives, processes for their production, pharmaceutical compositions containing them and their use
DK72282A (da) Fremgangsmaade til fremstilling af bis-estere af 1,1-alkandioler med 2beta-acetoxymethyl-2alfa-methyl-(5r)penam-3alfa-carboxylsyre-1,1-dioxid og en 6-acylaminopenicillansyre eller farmaceutisk acceptable salte deraf
PT72401A (en) Process for the preparation of an insecticidal and/or acaricidal composition containing esters of substituted 3-(1,2-dibromoalkyl)-2,2-dimethyl cyclopropan-1-carboxylic acids
SE8200679L (sv) 1-bensyl-4-(4-(2-pyrimidinylamino) bensyl 1-2,3-dioxopiperazinderivat, salter derav, forfarande for framstellning derav och karcinostatiska medel der de ingar
DK159272C (da) Analogifremgangsmaade til fremstilling af alfa-substitueret ureidobenzylpenicillansyre
DK0397048T3 (da) Fremgangsmåde til fremstilling af 2-mercapto-4-methyl-1,3-thiazol-5-yl-eddikesyre og dens estere
MC1421A1 (fr) Derives acyles
DK27081A (da) Indan-4-yl-n-alkyl-carbaminsyreestere,fremgangsmaade til fremstilling heraf samt deres anvendelse som fungicider
JPS53149932A (en) 2-(3-alkylnitrosoureido)-hexapyranoside derivatives
ES8602016A1 (es) Un procedimiento para obtener derivados de cefalosporina
GB855430A (en) Certain esters of amino alcohols
JPS53149931A (en) 2-(3-alkylureido)-hexapyranoside derivatives
DE58909745D1 (de) Tetrahydro-4-phenylimino-3-thiophenessigsäuren

Legal Events

Date Code Title Description
PBP Patent lapsed